Cas no 107864-79-9 (3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one)
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one Chemical and Physical Properties
Names and Identifiers
-
- 3-Hydroxy-3-(2-oxopropyl)-1-propylindolin-2-one
- 2H-Indol-2-one,1,3-dihydro-3-hydroxy-3-(2-oxopropyl)-1-propyl-
- 3-HYDROXY-3-(2-OXO-PROPYL)-1-PROPYL-1,3-DIHYDRO-INDOL-2-ONE
- 3-hydroxy-3-(2-oxopropyl)-1-propylindol-2-one
- 1-n-Propyl-3-acetonyl-3-hydroxyoxindole
- 3-hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one
- AC1MF437
- ACMC-20mb83
- Ambcb6161101
- CTK4A5747
- STK889339
- 3-hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one(SALTDATA: FREE)
- SR-01000428943-1
- AKOS000550144
- EU-0037717
- DTXSID20387401
- MFCD01817193
- AKOS016165856
- BS-36867
- SB65603
- SR-01000428943
- 107864-79-9
- 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one
-
- MDL: MFCD01817193
- Inchi: 1S/C14H17NO3/c1-3-8-15-12-7-5-4-6-11(12)14(18,13(15)17)9-10(2)16/h4-7,18H,3,8-9H2,1-2H3
- InChI Key: OOANHZQZDVVMAI-UHFFFAOYSA-N
- SMILES: OC1(CC(C)=O)C(N(CCC)C2C=CC=CC1=2)=O
Computed Properties
- Exact Mass: 247.12091
- Monoisotopic Mass: 247.121
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 18
- Rotatable Bond Count: 4
- Complexity: 355
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.3
- Topological Polar Surface Area: 57.6?2
Experimental Properties
- Density: 1.195
- Boiling Point: 486.1°C at 760 mmHg
- Flash Point: 247.8°C
- Refractive Index: 1.56
- PSA: 57.61
- LogP: 1.67490
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | H954273-50mg |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one |
107864-79-9 | 50mg |
$ 50.00 | 2022-06-04 | ||
| TRC | H954273-100mg |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one |
107864-79-9 | 100mg |
$ 65.00 | 2022-06-04 | ||
| TRC | H954273-500mg |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one |
107864-79-9 | 500mg |
$ 230.00 | 2022-06-04 | ||
| Chemenu | CM257387-1g |
3-Hydroxy-3-(2-oxopropyl)-1-propylindolin-2-one |
107864-79-9 | 95% | 1g |
$114 | 2023-11-25 | |
| abcr | AB220859-1 g |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one; 95% |
107864-79-9 | 1g |
€137.20 | 2023-06-22 | ||
| abcr | AB220859-1g |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one, 95%; . |
107864-79-9 | 95% | 1g |
€137.20 | 2024-06-10 | |
| 1PlusChem | 1P0084OW-1g |
2H-Indol-2-one,1,3-dihydro-3-hydroxy-3-(2-oxopropyl)-1-propyl- |
107864-79-9 | 95% | 1g |
$72.00 | 2025-02-22 | |
| A2B Chem LLC | AD78528-1g |
3-Hydroxy-3-(2-oxopropyl)-1-propylindolin-2-one |
107864-79-9 | 95% | 1g |
$61.00 | 2024-04-20 | |
| Ambeed | A732107-1g |
3-Hydroxy-3-(2-oxopropyl)-1-propylindolin-2-one |
107864-79-9 | 95+% | 1g |
$108.0 | 2024-04-26 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1812722-1g |
3-Hydroxy-3-(2-oxopropyl)-1-propylindol-2-one |
107864-79-9 | 95% | 1g |
¥2106.00 | 2024-08-09 |
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one Related Literature
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
Additional information on 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one
Introduction to 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one (CAS No. 107864-79-9) and Its Emerging Applications in Chemical Biology
3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one, identified by its CAS number 107864-79-9, is a structurally complex organic compound that has garnered significant attention in the field of chemical biology due to its unique pharmacophoric features. This indole derivative exhibits a molecular framework characterized by a hydroxyl group, an alkoxy side chain, and a dihydropyridone core, which collectively contribute to its intriguing biological activities. The compound’s chemical structure not only makes it a subject of interest for synthetic chemists but also positions it as a potential candidate for further exploration in medicinal chemistry and drug discovery.
The synthesis of 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one involves multi-step organic transformations, including condensation reactions, cyclization processes, and functional group modifications. The precise arrangement of substituents on the indole scaffold is critical for achieving the desired biological properties. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been employed to enhance the efficiency and selectivity of the synthesis. These approaches underscore the compound’s synthetic challenge and highlight the expertise required to produce it in high purity.
Recent studies have demonstrated that 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one possesses notable pharmacological effects that warrant further investigation. Research indicates that this compound may interact with various biological targets, including enzymes and receptors involved in metabolic pathways. Specifically, preliminary in vitro assays have suggested potential activity against enzymes such as cytochrome P450 monooxygenases and xanthine oxidase, which are implicated in inflammatory responses and oxidative stress. These findings align with the growing interest in indole derivatives as modulators of cellular signaling pathways.
The structural motif of 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one also suggests potential applications in addressing neurological disorders. Indole derivatives have long been recognized for their role in modulating neurotransmitter systems, particularly serotonin and dopamine pathways. The presence of a hydroxyl group and an alkoxy side chain may enhance binding affinity to specific serotonin receptor subtypes, which are associated with mood regulation and cognitive functions. Furthermore, the dihydropyridone core could contribute to neuroprotective effects by interfering with oxidative damage mechanisms in neuronal cells.
In the realm of drug discovery, the development of novel scaffolds is essential for overcoming resistance mechanisms and improving therapeutic outcomes. 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one represents an innovative chemical entity that combines structural diversity with functional versatility. Its unique combination of pharmacophoric elements makes it a valuable scaffold for designing next-generation therapeutics. By leveraging computational chemistry tools such as molecular docking and virtual screening, researchers can identify optimized analogs with enhanced efficacy and reduced toxicity profiles.
The compound’s potential extends beyond traditional pharmaceutical applications; it also holds promise in agrochemical research. Indole derivatives are known to exhibit phytotoxic properties when appropriately modified, making them candidates for developing novel herbicides or plant growth regulators. The structural features of 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one could be tailored to target specific enzymatic pathways in plants while minimizing environmental impact. Such developments would align with global efforts to create sustainable agricultural practices.
From a chemical biology perspective, 3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one serves as a valuable tool for understanding complex biological processes at the molecular level. Its interaction with biological targets can provide insights into disease mechanisms and therapeutic strategies. For instance, studying how this compound modulates enzyme activity or receptor binding can reveal key insights into metabolic disorders or neurodegenerative diseases. Such mechanistic studies are crucial for translating laboratory findings into effective clinical interventions.
The synthesis and characterization of 3-Hydroxy-3-(2-oxpropy l)-1-prop yl - 1 , 3 - dihydro - 2 H - ind ol - 2 - one (CAS No. 107864 - 79 - 9) also contribute to advancements in synthetic methodology and analytical techniques. High-resolution spectroscopic methods such as NMR spectroscopy (1H and 13C), mass spectrometry (LCMS), and X-ray crystallography are employed to elucidate its structure and confirm purity levels required for biological testing. These techniques not only validate synthetic routes but also provide critical data for understanding its physicochemical properties.
The future prospects of 3-Hydroxy - 3 - ( 2 - oxoprop yl ) - 1 - prop yl - 1 , 3 - dihydro - 2 H - ind ol - 2 - one are vast and multifaceted. Ongoing research aims to optimize its pharmacokinetic properties through structural modifications while maintaining or enhancing its biological activity. Collaborative efforts between synthetic chemists, biochemists, and pharmacologists will be essential in realizing its full potential as a therapeutic agent or bioactive molecule.
107864-79-9 (3-Hydroxy-3-(2-oxopropyl)-1-propyl-1,3-dihydro-2H-indol-2-one) Related Products
- 33417-17-3(3-Hydroxy-3-(2-oxo-propyl)-1,3-dihydro-indol-2-one)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)